Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7R98

Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody B6

Replaces:  7N0S
Summary for 7R98
Entry DOI10.2210/pdb7r98/pdb
DescriptorNucleoprotein, Nanobody B6 (2 entities in total)
Functional Keywordssars-cov-2, nanobody, nucleocapsid, virus, viral protein-immune system complex, rna binding protein, viral protein/immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
More
Total number of polymer chains6
Total formula weight86928.52
Authors
Corbett, K.D.,Ye, Q. (deposition date: 2021-06-28, release date: 2021-07-07, Last modification date: 2024-10-09)
Primary citationYe, Q.,Lu, S.,Corbett, K.D.
Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies.
Front Immunol, 12:719037-719037, 2021
Cited by
PubMed Abstract: The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, is the most severe public health event of the twenty-first century. While effective vaccines against SARS-CoV-2 have been developed, there remains an urgent need for diagnostics to quickly and accurately detect infections. Antigen tests, particularly those that detect the abundant SARS-CoV-2 Nucleocapsid protein, are a proven method for detecting active SARS-CoV-2 infections. Here we report high-resolution crystal structures of three llama-derived single-domain antibodies that bind the SARS-CoV-2 Nucleocapsid protein with high affinity. Each antibody recognizes a specific folded domain of the protein, with two antibodies recognizing the N-terminal RNA binding domain and one recognizing the C-terminal dimerization domain. The two antibodies that recognize the RNA binding domain affect both RNA binding affinity and RNA-mediated phase separation of the Nucleocapsid protein. All three antibodies recognize highly conserved surfaces on the Nucleocapsid protein, suggesting that they could be used to develop affordable diagnostic tests to detect all circulating SARS-CoV-2 variants.
PubMed: 34381460
DOI: 10.3389/fimmu.2021.719037
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.51 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon